If you made any changes in Pure, your changes will be visible here soon.

Research Output 2000 2019

2019
24 Citations (Scopus)

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

ECHELON-2 Study Group, Jan 19 2019, In : The Lancet. 393, 10168, p. 229-240 12 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Drug Therapy
Vincristine
Prednisone
Doxorubicin

Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma

Khashab, T., Hagemeister, F., Romaguera, J. E., Fanale, M. A., Pro, B., McLaughlin, P., Rodriguez, M. A., Neelapu, S. S., Fayad, L., Younes, A., Feng, L., Vega, F., Kwak, L. W. & Samaniego, F., May 1 2019, In : British Journal of Haematology. 185, 4, p. 670-678 9 p.

Research output: Contribution to journalArticle

Pentostatin
Non-Hodgkin's Lymphoma
Cyclophosphamide
Disease-Free Survival
Survival Rate
1 Citation (Scopus)

Novel therapies and approaches to relapsed/refractory HL beyond chemotherapy

Mina, A. A., Vakkalagadda, C. & Pro, B., Mar 1 2019, In : Cancers. 11, 3, 421.

Research output: Contribution to journalReview article

Open Access
Hodgkin Disease
Salvage Therapy
Drug Therapy
Stem Cells
Transplants

Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry

Lansigan, F., Horwitz, S. M., Pinter-Brown, L. C., Rosen, S. T., Pro, B., Hsi, E. D., Federico, M., Gisselbrecht, C., Schwartz, M., Bellm, L. A., Acosta, M., Shustov, A. R., Advani, R. H., Feldman, T., Lechowicz, M. J., Smith, S. M., Tulpule, A., Craig, M. D., Greer, J. P., Kahl, B. S. & 5 others, Leach, J. W., Morganstein, N., Casulo, C., Park, S. I. & Foss, F. M., Jan 1 2019, In : Acta Haematologica.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Registries
Therapeutics
Survival
T-Cell Lymphoma

Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry

Stuver, R. N., Khan, N., Schwartz, M., Acosta, M., Federico, M., Gisselbrecht, C., Horwitz, S. M., Lansigan, F., Pinter-Brown, L. C., Pro, B., Shustov, A. R., Foss, F. M. & Jain, S., Jun 1 2019, In : American Journal of Hematology. 94, 6, p. 641-649 9 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Combination Drug Therapy
Registries
Retreatment
Therapeutics

Survival outcomes of diffuse large B-cell lymphoma by association with concurrent or antecedent follicular lymphoma and double hit status

Behdad, A., Boddy, C. S., Fought, A. J., Taxter, T., Falkiewicz, M. K., Ayers, E., Chen, Q. C., Chen, Y-H., Karmali, R., Pro, B., Winter, J. N., Landsburg, D. J., Gordon, L. I. & Kaplan, J. B., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Follicular Lymphoma
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Lymphoma

The histological prevalence and clinical implications of folliculotropism and syringotropism in mycosis fungoides

Hossain, C., Jennings, T., Duffy, R., Knoblauch, K., Gochoco, A., Chervoneva, I., Shi, W., Alpdogan, S. O., Porcu, P., Pro, B. & Sahu, J., Feb 1 2019, In : Chinese clinical oncology. 8, 1, 1 p.

Research output: Contribution to journalArticle

Mycosis Fungoides
Pruritus
Biopsy
Cutaneous T-Cell Lymphoma
Sweat Glands
2 Citations (Scopus)
Peripheral T-Cell Lymphoma
Stem Cell Transplantation
Multicenter Studies
Cohort Studies
Survival
2018
1 Citation (Scopus)

Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged Neoplasm

Behdad, A., Allen, P., Lu, X., Zhou, A., Guitart, J., Chen, Q. C. & Pro, B., Aug 1 2018, In : The American Journal of dermatopathology. 40, 8, p. 610-613 4 p.

Research output: Contribution to journalArticle

Cutaneous T-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Drug Therapy
Neoplasms
T-Cell Lymphoma
Anaplastic Large-Cell Lymphoma
Refractory materials
Blood
cAC10-vcMMAE
12 Citations (Scopus)

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas

Fanale, M. A., Horwitz, S. M., Forero-Torres, A., Bartlett, N. L., Advani, R. H., Pro, B., Chen, R. W., Davies, A., Illidge, T., Uttarwar, M., Lee, S. Y., Ren, H., Kennedy, D. A. & Shustov, A. R., May 10 2018, In : Blood. 131, 19, p. 2120-2124 5 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
T-cells
Transplants
Prednisone
Stem cells
3 Citations (Scopus)

Hemophagocytic lymphohistiocytosis in cutaneous T-cell lymphoma

Lee, D. E., Martinez-Escala, M. E., Serrano, L. M., Zhou, X. A., Kaplan, J. B., Pro, B., Choi, J. & Guitart, J., Jul 1 2018, In : JAMA Dermatology. 154, 7, p. 828-831 4 p.

Research output: Contribution to journalArticle

Hemophagocytic Lymphohistiocytosis
Cutaneous T-Cell Lymphoma
Subcutaneous Tissue
Stem Cell Transplantation
Therapeutics
36 Citations (Scopus)

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

MAVORIC Investigators, Sep 1 2018, In : The Lancet Oncology. 19, 9, p. 1192-1204 13 p.

Research output: Contribution to journalArticle

Cutaneous T-Cell Lymphoma
Mycosis Fungoides
Research Personnel
Disease-Free Survival
Therapeutics
4 Citations (Scopus)

Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma

Romaguera, J. E., Wang, M., Feng, L., Fayad, L. E., Hagemeister, F., McLaughlin, P., Rodriguez, M. A., Fanale, M., Orlowski, R., Kwak, L. W., Neelapu, S., Oki, Y., Pro, B., Younes, A., Samaniego, F., Fowler, N., Hartig, K., Valentinetti, M., Smith, J., Ford, P. & 4 others, Naig, A., Medeiros, L. J., Kantarjian, H. M. & Goy, A., Jun 15 2018, In : Cancer. 124, 12, p. 2561-2569 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cytarabine
Vincristine
Methotrexate
Doxorubicin
9 Citations (Scopus)

Progression of undiagnosed cutaneous lymphoma after anti–tumor necrosis factor-alpha therapy

Martinez-Escala, M. E., Posligua, A. L., Wickless, H., Rutherford, A., Sable, K. A., Rubio-Gonzalez, B., Zhou, A., Kaplan, J. B., Pro, B., Choi, J., Querfeld, C., Rosen, S. T. & Guitart, J., Jun 1 2018, In : Journal of the American Academy of Dermatology. 78, 6, p. 1068-1076 9 p.

Research output: Contribution to journalArticle

Lymphoma
Necrosis
Skin
Cutaneous T-Cell Lymphoma
B-Cell Lymphoma
7 Citations (Scopus)

T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., Clemens, M. W., Dogan, A., Greer, J. P., Halwani, A., Bradley, M. H., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Kim, Y. H., Lunning, M. A., Mehta, A., Mehta-Shah, N., Oki, Y., Olsen, E. A. & 11 others, Pro, B., Rajguru, S. A., Shanbhag, S., Shustov, A., Sokol, L., Torka, P., Wilcox, R., William, B., Zain, J., Dwyer, M. A. & Sundar, H., Feb 1 2018, In : JNCCN Journal of the National Comprehensive Cancer Network. 16, 2, p. 123-135 13 p.

Research output: Contribution to journalReview article

T-Cell Lymphoma
Natural Killer T-Cells
Guidelines
Extranodal NK-T-Cell Lymphoma
Nose

Transforming growth factor superfamily ligands and links to tumorigenesis

Akpan, I., Pro, B. & Platanias, L. C., Jun 3 2018, In : Leukemia and Lymphoma. 59, 6, p. 1282-1283 2 p.

Research output: Contribution to journalComment/debate

Transforming Growth Factors
Carcinogenesis
Ligands
2017
5 Citations (Scopus)

Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States

Hsi, E. D., Horwitz, S. M., Carson, K. R., Pinter-Brown, L. C., Rosen, S. T., Pro, B., Federico, M., Gisselbrecht, C., Schwartz, M., Bellm, L. A., Acosta, M., Collie, A. M., Gruver, A. M., Grzywacz, B. J., Turakhia, S., Shustov, A. R., Advani, R. H., Feldman, T., Lechowicz, M. J., Smith, S. M. & 10 others, Lansigan, F., Tulpule, A., Craig, M. D., Greer, J. P., Kahl, B. S., Leach, J. W., Morganstein, N., Casulo, C., Park, S. I. & Foss, F. M., Apr 1 2017, In : Clinical Lymphoma, Myeloma and Leukemia. 17, 4, p. 193-200 8 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
T-Cell Lymphoma
Anaplastic Large-Cell Lymphoma
Lymphoma
Cohort Studies
16 Citations (Scopus)

A prospective cohort study of patients with peripheral T-cell lymphoma in the United States

Carson, K. R., Horwitz, S. M., Pinter-Brown, L. C., Rosen, S. T., Pro, B., Hsi, E. D., Federico, M., Gisselbrecht, C., Schwartz, M., Bellm, L. A., Acosta, M. A., Shustov, A. R., Advani, R. H., Feldman, T. A., Lechowicz, M. J., Smith, S. M., Lansigan, F., Tulpule, A., Craig, M. D., Greer, J. P. & 6 others, Kahl, B. S., Leach, J. W., Morganstein, N., Casulo, C., Park, S. I. & Foss, F. M., Apr 1 2017, In : Cancer. 123, 7, p. 1174-1183 10 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Cohort Studies
Prospective Studies
Doxorubicin
Therapeutics
115 Citations (Scopus)

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

Prince, H. M., Kim, Y. H., Horwitz, S. M., Dummer, R., Scarisbrick, J., Quaglino, P., Zinzani, P. L., Wolter, P., Sanches, J. A., Ortiz-Romero, P. L., Akilov, O. E., Geskin, L., Trotman, J., Taylor, K., Dalle, S., Weichenthal, M., Walewski, J., Fisher, D., Dréno, B., Stadler, R. & 46 others, Feldman, T., Kuzel, T. M., Wang, Y., Palanca-Wessels, M. C., Zagadailov, E., Trepicchio, W. L., Zhang, W., Lin, H. M., Liu, Y., Huebner, D., Little, M., Whittaker, S., Duvic, M., Joske, D., Lewis, I. D., Jonak, C., Trautinger, F., Bechter, O., Bron, D., de Lima, V. C. C., Klasa, R., Bagot, M., Beylot-Barry, M., D'Incan, M., Dreno, B., Grange, F., Nicolay, J., Wobser, M., Assaf, C., Loquai, C., Spina, M., Bosi, A., Fattori, P. P., Grzanka, A., Lopez-Hernandez, A., Roca, J. J. R., Canales, S. N., Illidge, T., Johnson, R., Morris, S., McKay, P., Pro, B., Lerner, A., Eradat, H., Sokol, L. & Hughey, S., Aug 1 2017, In : The Lancet. 390, 10094, p. 555-566 12 p.

Research output: Contribution to journalArticle

Cutaneous T-Cell Lymphoma
Multicenter Studies
Physicians
Methotrexate
cAC10-vcMMAE
10 Citations (Scopus)

CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder

Martinez-Escala, M. E., Kantor, R. W., Cices, A., Zhou, A., Kaplan, J. B., Pro, B., Choi, J. & Guitart, J., Sep 1 2017, In : Journal of the American Academy of Dermatology. 77, 3, p. 489-496 8 p.

Research output: Contribution to journalArticle

Mycosis Fungoides
Lymphoproliferative Disorders
Surface Antigens
Observation
Pediatrics
27 Citations (Scopus)

Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation

Kharfan-Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C., d'Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A., Foss, F., Advani, R., Fenske, T. S., Lazarus, H. M., Friedberg, J. W., Aljurf, M., Sokol, L., Tobinai, K., Tse, E., Burns, L. J. & 14 others, Chavez, J. C., Reddy, N. M., Suzuki, R., Ahmed, S., Nademanee, A., Mohty, M., Gopal, A. K., Fanale, M. A., Pro, B., Moskowitz, A. J., Sureda, A., Perales, M. A., Carpenter, P. A. & Savani, B. N., Nov 1 2017, In : Biology of Blood and Marrow Transplantation. 23, 11, p. 1826-1838 13 p.

Research output: Contribution to journalArticle

Natural Killer T-Cells
T-Cell Lymphoma
Cell Transplantation
Lymphoma
Enteropathy-Associated T-Cell Lymphoma
32 Citations (Scopus)

Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

Pro, B., Advani, R., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M., Connors, J. M., Fenton, K., Huebner, D., Pinelli, J. M., Kennedy, D. A. & Shustov, A., Dec 21 2017, In : Blood. 130, 25, p. 2709-2717 9 p.

Research output: Contribution to journalArticle

Anaplastic Large-Cell Lymphoma
Transplants
Stem cells
Refractory materials
Stem Cells
19 Citations (Scopus)

Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E)

Park, J., Yang, J., Wenzel, A. T., Ramachandran, A., Lee, W. J., Daniels, J. C., Kim, J., Martinez-Escala, E., Amankulor, N., Pro, B., Guitart, J., Mendillo, M. L., Savas, J. N., Boggon, T. J. & Choi, J., Sep 21 2017, In : Blood. 130, 12, p. 1430-1440 11 p.

Research output: Contribution to journalArticle

Cutaneous T-Cell Lymphoma
T-cells
NF-kappa B
T-Cell Antigen Receptor
T-Lymphocytes
5 Citations (Scopus)

Hodgkin lymphoma: A complex metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment

Mikkilineni, L., Whitaker-Menezes, D., Domingo-Vidal, M., Sprandio, J., Avena, P., Cotzia, P., Dulau-Florea, A., Gong, J., Uppal, G., Zhan, T., Leiby, B., Lin, Z., Pro, B., Sotgia, F., Lisanti, M. P. & Martinez-Outschoorn, U., Jun 1 2017, In : Seminars in Oncology. 44, 3, p. 218-225 8 p.

Research output: Contribution to journalArticle

Tumor Microenvironment
Hodgkin Disease
Ecosystem
Mitochondrial Membranes
Neoplasms
8 Citations (Scopus)

Report of the 6th International Workshop on PET in lymphoma

Nanni, C., Cottereau, A. S., Lopci, E., Bodet-Milin, C., Coronado, M., Pro, B., Kim, W. S., Trotman, J., Barrington, S., Duhrsen, U., Vander Borght, T., Zamagni, E., Kraeber-Bodéré, F., Messiou, C., Rahmouni, A., Buvat, I., Andre, M., Hertzberg, M., Oyen, W., Casasnovas, O. & 12 others, Luminari, S., Garderet, L., Montravers, F., Kobe, C., Kluge, R., Versari, A., Zucca, E., Moreau, P., Cheson, B., Haioun, C., Gallamini, A. & Meignan, M., Oct 3 2017, In : Leukemia and Lymphoma. 58, 10, p. 2298-2303 6 p.

Research output: Contribution to journalArticle

Positron-Emission Tomography
Lymphoma
Education
Multiple Myeloma
Peripheral T-Cell Lymphoma
5 Citations (Scopus)

Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma

Foss, F., Pro, B., Miles Prince, H., Sokol, L., Caballero, D., Horwitz, S. & Coiffier, B., Jan 1 2017, In : Cancer medicine. 6, 1, p. 36-44 9 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Therapeutics
romidepsin
Salvage Therapy
Histone Deacetylase Inhibitors
7 Citations (Scopus)

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

Pro, B., Horwitz, S. M., Prince, H. M., Foss, F. M., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Wilhelm, M., Iyer, S. P., Shustov, A. R., Wolfson, J., Balser, B. E. & Coiffier, B., Dec 1 2017, In : Hematological Oncology. 35, 4, p. 914-917 4 p.

Research output: Contribution to journalLetter

T-Cell Lymphoma
romidepsin
3 Citations (Scopus)

Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials

Shustov, A., Coiffier, B., Horwitz, S., Sokol, L., Pro, B., Wolfson, J., Balser, B., Eisch, R., Popplewell, L., Prince, H. M., Allen, S. L., Piekarz, R. & Bates, S., Oct 3 2017, In : Leukemia and Lymphoma. 58, 10, p. 2335-2341 7 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Salvage Therapy
Histone Deacetylase Inhibitors
romidepsin
Disease-Free Survival
2016
34 Citations (Scopus)

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): Final results from the T- cell consortium trial

Advani, R. H., Ansell, S. M., Lechowicz, M. J., Beaven, A. W., Loberiza, F., Carson, K. R., Evens, A. M., Foss, F., Horwitz, S., Pro, B., Pinter-Brown, L. C., Smith, S. M., Shustov, A. R., Savage, K. J. & Vose, J. M., Feb 1 2016, In : British Journal of Haematology. 172, 4, p. 535-544 10 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Vincristine
Etoposide
Prednisone
Cyclophosphamide
10 Citations (Scopus)

A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

Gaballa, S., Palmisiano, N., Alpdogan, O., Carabasi, M., Filicko-O'Hara, J., Kasner, M., Kraft, W. K., Leiby, B., Martinez-Outschoorn, U., O'Hara, W., Pro, B., Rudolph, S., Sharma, M., Wagner, J. L., Weiss, M., Flomenberg, N. & Grosso, D., Jan 1 2016, In : Biology of Blood and Marrow Transplantation. 22, 1, p. 141-148 8 p.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
Research Design
Graft vs Host Disease
Stem Cell Transplantation
T-Lymphocytes
2 Citations (Scopus)

Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: Results of a randomized phase II trial

Karuturi, M., Younes, A., Fayad, L., Kwak, L., Pro, B., Shah, J., Oki, Y., Simien, R., Liboon, M. J., Hutto, T., Feng, L., Horowitz, S., Nieto, Y., Anderlini, P., Alousi, A., Popat, U., Medeiros, L. J., Miranda, R. & Fanale, M., Feb 1 2016, In : Leukemia and Lymphoma. 57, 2, p. 445-447 3 p.

Research output: Contribution to journalLetter

Ifosfamide
Carboplatin
Etoposide
Hodgkin Disease
Bortezomib

Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial setting

Gopal, A. K., Pro, B., Connors, J. M., Younes, A., Engert, A., Shustov, A. R., Chi, X., Larsen, E. K., Kennedy, D. A. & Sievers, E. L., Oct 1 2016, In : Clinical Trials. 13, 5, p. 545-554 10 p.

Research output: Contribution to journalReview article

Lymphoma
Clinical Trials
Anaplastic Large-Cell Lymphoma
Hodgkin Disease
Confidence Intervals
36 Citations (Scopus)

Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center

Chihara, D., Cheah, C. Y., Westin, J. R., Fayad, L. E., Rodriguez, M. A., Hagemeister, F. B., Pro, B., Mclaughlin, P., Younes, A., Samaniego, F., Goy, A., Cabanillas, F., Kantarjian, H., Kwak, L. W., Wang, M. L. & Romaguera, J. E., Jan 1 2016, In : British Journal of Haematology. 172, 1, p. 80-88 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Cytarabine
Survival
Neoplasms
Myelodysplastic Syndromes
14 Citations (Scopus)

Romidepsin for the treatment of relapsed/refractory peripheral T cell lymphoma: prolonged stable disease provides clinical benefits for patients in the pivotal trial

Foss, F., Horwitz, S., Pro, B., Prince, H. M., Sokol, L., Balser, B., Wolfson, J. & Coiffier, B., Mar 10 2016, In : Journal of Hematology and Oncology. 9, 1, 243.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Therapeutics
Maintenance
romidepsin
Histone Deacetylase Inhibitors
2015
24 Citations (Scopus)

A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease

Grosso, D., Gaballa, S., Alpdogan, O., Carabasi, M., Filicko-O'Hara, J., Kasner, M., Martinez-Outschoorn, U., Wagner, J. L., O'Hara, W., Rudolph, S., Chervoneva, I., Colombe, B., Farley, P. C., Flomenberg, P., Pro, B., Sharma, M., Shi, W., Weiss, M. & Flomenberg, N., Apr 1 2015, In : Biology of Blood and Marrow Transplantation. 21, 4, p. 646-652 7 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Transplantation
Survival
Mortality
Tissue Donors
2 Citations (Scopus)

Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins’ Lymphoma in First Remission

Sharma, M. & Pro, B., Jul 18 2015, In : Current treatment options in oncology. 16, 7, 34.

Research output: Contribution to journalReview article

Peripheral T-Cell Lymphoma
Bone Marrow Transplantation
Non-Hodgkin's Lymphoma
Stem Cell Transplantation
Anaplastic Large-Cell Lymphoma
16 Citations (Scopus)

Comparison of survival in patients with t cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease

Beitinjaneh, A., Saliba, R. M., Medeiros, L. J., Turturro, F., Rondon, G., Korbling, M., Fayad, L., Fanale, M. A., Alousi, A. M., Anderlini, P., Betul, O., Popat, U. R., Pro, B. & Khouri, I. F., May 1 2015, In : Biology of Blood and Marrow Transplantation. 21, 5, p. 855-859 5 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Lymphoma
Survival
Survival Rate
T-Cell Lymphoma
4 Citations (Scopus)

Current management of peripheral t-cell lymphomas

Gooptu, M., Rhoades, R. & Pro, B., Jan 1 2015, In : Cancer treatment and research. 165, p. 289-303 15 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Lymphoma
Aurora Kinases
Anaplastic Large-Cell Lymphoma
Immunotoxins

Kaposi sarcoma mimicking multiple cherry angiomata clinically and histologically in a patient with sezary syndrome: An unusual presentation

Hannaway, M., Zendell, K., Osley, K., Alpdogan, O., Pro, B. & Sahu, J., Jan 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 1, p. e35-e37

Research output: Contribution to journalArticle

Sezary Syndrome
Cutaneous T-Cell Lymphoma
Kaposi's Sarcoma
Skin Neoplasms
Hemangioma
20 Citations (Scopus)

Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: An open label, single arm, phase II trial

Oki, Y., Ewer, M. S., Lenihan, D. J., Fisch, M. J., Hagemeister, F. B., Fanale, M., Romaguera, J., Pro, B., Fowler, N., Younes, A., Astrow, A. B., Huang, X., Kwak, L. W., Samaniego, F., McLaughlin, P., Neelapu, S. S., Wang, M., Fayad, L. E., Durand, J. B. & Alma Rodriguez, M., Mar 1 2015, In : Clinical Lymphoma, Myeloma and Leukemia. 15, 3, p. 152-158 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Doxorubicin
Vincristine
Prednisone
Cyclophosphamide
2 Citations (Scopus)

Pentostatin, cyclophosphamide and rituximab for previously untreated advanced stage, low-grade B-cell lymphomas

Samaniego, F., Hagemeister, F., Romaguera, J. E., Fanale, M. A., Pro, B., Mclaughlin, P., Rodriguez, M. A., Neelapu, S. S., Fayad, L., Younes, A., Feng, L., Berkova, Z., Khashab, T., Sehgal, L., Vega-Vasquez, F. & Kwak, L. W., Jan 1 2015, In : British Journal of Haematology. 169, 6, p. 814-823 10 p.

Research output: Contribution to journalArticle

Pentostatin
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Cyclophosphamide
Confidence Intervals
9 Citations (Scopus)

Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma

Chihara, D., Pro, B., Loghavi, S., Miranda, R. N., Medeiros, L. J., Fanale, M. A., Hagemeister, F. B., Fayad, L. E., Romaguera, J. E., Samaniego, F., Neelapu, S. S., Younes, A., Fowler, N. H., Rodriguez, M. A., Wang, M., Kwak, L. W., Mclaughlin, P., Dang, N. H. & Oki, Y., Nov 1 2015, In : British Journal of Haematology. 171, 4, p. 509-516 8 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Thrombocytopenia
Disease-Free Survival
Anaplastic Large-Cell Lymphoma
Survival
7 Citations (Scopus)

Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma

Horwitz, S., Coiffier, B., Foss, F., Prince, H. M., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Pinter-Brown, L., Iyer, S. P., Shustov, A., Nichols, J., Balser, J., Balser, B. & Pro, B., Jan 1 2015, In : Annals of Oncology. 26, 4, p. 774-779 6 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Deoxyglucose
Positron-Emission Tomography
Radiology
Education
2014
9 Citations (Scopus)

90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease

Samaniego, F., Berkova, Z., Romaguera, J. E., Fowler, N., Fanale, M. A., Pro, B., Shah, J. J., Mclaughlin, P., Sehgal, L., Selvaraj, V., Braun, F. K., Mathur, R., Feng, L., Neelapu, S. S. & Kwak, L. W., Jan 1 2014, In : British Journal of Haematology. 167, 2, p. 207-213 7 p.

Research output: Contribution to journalArticle

B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Radiotherapy
Follicular Lymphoma
Therapeutics
92 Citations (Scopus)

Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral t-cell lymphomas: Results of a phase i study

Fanale, M. A., Horwitz, S. M., Forero-Torres, A., Bartlett, N. L., Advani, R. H., Pro, B., Chen, R. W., Davies, A., Illidge, T., Huebner, D., Kennedy, D. A. & Shustov, A. R., Oct 1 2014, In : Journal of Clinical Oncology. 32, 28, p. 3137-3143 7 p.

Research output: Contribution to journalArticle

Lymphoma
Peripheral T-Cell Lymphoma
Survival Rate
Disease-Free Survival
Vincristine
21 Citations (Scopus)

Clinical features, management and prognosis of multifocal primary bone lymphoma: A retrospective study of the international extranodal lymphoma study group (the IELSG 14 study)

Messina, C., Ferreri, A. J. M., Govi, S., Bruno-Ventre, M., Gracia Medina, E. A., Porter, D., Radford, J., Heo, D. S., Park, H. Y., Pro, B., Jayamohan, J., Visco, C., Scarfò, L., Zucca, E., Gospodarowicz, M. & Christie, D., Mar 1 2014, In : British Journal of Haematology. 164, 6, p. 834-840 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Retrospective Studies
Bone and Bones
Radiotherapy
7 Citations (Scopus)

Paclitaxel, topotecan and rituximab: Long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma

Westin, J. R., Mclaughlin, P., Romaguera, J., Hagemeister, F. B., Pro, B., Dang, N. H., Samaniego, F., Rodriguez, M. A., Fayad, L., Oki, Y., Fanale, M., Fowler, N., Nastoupil, L., Feng, L., Loyer, E. & Younes, A., Jan 1 2014, In : British Journal of Haematology. 167, 2, p. 177-184 8 p.

Research output: Contribution to journalArticle

Topotecan
B-Cell Lymphoma
Paclitaxel
Platinum
Non-Hodgkin's Lymphoma
99 Citations (Scopus)

Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: Pivotal study update demonstrates durable responses

Coiffier, B., Pro, B., Prince, H. M., Foss, F., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Wilhelm, M., Pinter-Brown, L., Padmanabhan Iyer, S., Shustov, A., Nielsen, T., Nichols, J., Wolfson, J., Balser, B. & Horwitz, S., Jan 23 2014, In : Journal of Hematology and Oncology. 7, 1, 11.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Therapeutics
romidepsin
Cutaneous T-Cell Lymphoma
Histone Deacetylase Inhibitors
201 Citations (Scopus)

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

Bollard, C. M., Gottschalk, S., Torrano, V., Diouf, O., Ku, S., Hazrat, Y., Carrum, G., Ramos, C., Fayad, L., Shpall, E. J., Pro, B., Liu, H., Wu, M. F., Lee, D., Sheehan, A. M., Zu, Y., Gee, A. P., Brenner, M. K., Heslop, H. E. & Rooney, C. M., Mar 10 2014, In : Journal of Clinical Oncology. 32, 8, p. 798-808 11 p.

Research output: Contribution to journalArticle

Cytotoxic T-Lymphocytes
Human Herpesvirus 4
Lymphoma
Membrane Proteins
Antigens